Breaking News Instant updates and real-time market news.

FATE

Fate Therapeutics

$12.47

0.14 (1.14%)

16:12
11/21/18
11/21
16:12
11/21/18
16:12

Fate Therapeutics files automatic mixed securities shelf

  • 27

    Nov

  • 30

    Nov

  • 01

    Dec

FATE Fate Therapeutics
$12.47

0.14 (1.14%)

09/18/18
PIPR
09/18/18
NO CHANGE
Target $25
PIPR
Overweight
Fate Therapeutics price target raised to $25 from $20 at Piper Jaffray
After Fate Therapeutics announced a collaboration with ONO Pharmaceutical for the joint development and commercialization of two off-the-shelf CAR-T cell product candidates, Piper Jaffray analyst Edward Tenthoff said he likes the deal as it expands Fate's iPSC CAR-T pipeline while also giving the company $70M in near-term funding. Following the collaboration pact, Tenthoff increased his price target on Fate shares to $25 and reiterated an Overweight rating.
09/25/18
PIPR
09/25/18
NO CHANGE
Target $23
PIPR
Overweight
Fate Therapeutics price target lowered to $23 from $25 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff lowered his price target for Fate Therapeutics to $23 to account for dilution from the equity issuance. He estimates Fate now holds proforma cash of $223M to advance and expand its clinical pipeline of off-the-shelf Natural Killer cell and CAR-T therapies. The analyst reiterates an Overweight rating on the shares.
11/05/18
JEFF
11/05/18
INITIATION
Target $17
JEFF
Buy
Fate Therapeutics initiated with a Buy at Jefferies
Jefferies analyst Biren Amin started Fate Therapeutics with a Buy rating and $17 price target. Natural killer cells possess advantageous cytotoxic properties distinct from T cells, and have demonstrated clinical efficacy against select cancer types, Amin tells investors in a research note. The analyst says Fate "offers a unique and potentially disruptive approach."
11/11/18
PIPR
11/11/18
NO CHANGE
Target $23
PIPR
Overweight
Fate Therapeutics' NK100 update at SITC 'encouraging,' says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff notes that Fate Therapeutics updated Phase I NK100 data and provided new details on iPSC platform expansion at SITC. NK100 activity was observed in 7/14 AML, ovarian cancer and solid tumor patients, with seven patients receiving two infusions with NK100 cell persistence through Day 21 without compromised cytotoxicity or viability, he added, highlighting that NK100 is safe with no cytokine release syndrome or neurotoxicity even after multiple doses. Tenthoff is most excited for Fate's transformative iPSC platform enabling unprecedented scalable and homogeneous manufacturing. As expected, Fate found no adventitious agents and expects the first-ever IND on iPSC-derived Natural Killer cell therapy FT500 to clear by year-end 2018, he contends. Tenthoff adds that the company is developing a pipeline of iPSC cell therapies and will file an IND on FT516 by year-end 2018. He reiterates an Overweight rating and $23 price target on the shares.

TODAY'S FREE FLY STORIES

WEX

Wex

$152.58

-0.875 (-0.57%)

05:07
12/11/18
12/11
05:07
12/11/18
05:07
Downgrade
Wex rating change  »

Wex downgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

FLT

FleetCor

$186.15

-0.78 (-0.42%)

05:06
12/11/18
12/11
05:06
12/11/18
05:06
Downgrade
FleetCor rating change  »

FleetCor downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

FIS

FIS

$105.72

1.07 (1.02%)

05:05
12/11/18
12/11
05:05
12/11/18
05:05
Upgrade
FIS rating change  »

FIS upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 13

    Dec

FISV

Fiserv

$76.15

1.42 (1.90%)

05:05
12/11/18
12/11
05:05
12/11/18
05:05
Upgrade
Fiserv rating change  »

Fiserv upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACOR

Acorda Therapeutics

$19.08

0.48 (2.58%)

05:03
12/11/18
12/11
05:03
12/11/18
05:03
Downgrade
Acorda Therapeutics rating change  »

Acorda Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jan

CAMP

CalAmp

$17.02

-0.23 (-1.33%)

05:01
12/11/18
12/11
05:01
12/11/18
05:01
Downgrade
CalAmp rating change  »

CalAmp downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMTX

SMTC Corp.

$3.63

-0.11 (-2.94%)

04:58
12/11/18
12/11
04:58
12/11/18
04:58
Initiation
SMTC Corp. initiated  »

SMTC Corp. initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NGHC

National General

$25.29

-0.09 (-0.35%)

04:57
12/11/18
12/11
04:57
12/11/18
04:57
Recommendations
National General analyst commentary  »

National General more…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BCOV

Brightcove

$7.04

(0.00%)

04:55
12/11/18
12/11
04:55
12/11/18
04:55
Upgrade
Brightcove rating change  »

Brightcove upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PGR

Progressive

$63.65

0.2 (0.32%)

04:55
12/11/18
12/11
04:55
12/11/18
04:55
Upgrade
Progressive rating change  »

Progressive upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLRX

BioLineRx

$0.66

0.005 (0.76%)

04:55
12/11/18
12/11
04:55
12/11/18
04:55
Conference/Events
BioLineRx to host investor meeting »

Investor Breakfast…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

ROCK

Gibraltar Industries

$34.29

-0.54 (-1.55%)

04:55
12/11/18
12/11
04:55
12/11/18
04:55
Conference/Events
Gibraltar Industries management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

WCN

Waste Connections

$76.66

-0.4 (-0.52%)

04:55
12/11/18
12/11
04:55
12/11/18
04:55
Conference/Events
Waste Connections management to meet with RBC Capital »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

GERN

Geron

$1.41

-0.08 (-5.37%)

04:55
12/11/18
12/11
04:55
12/11/18
04:55
Conference/Events
Geron management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

ADP

ADP

$139.77

0.44 (0.32%)

04:55
12/11/18
12/11
04:55
12/11/18
04:55
Conference/Events
ADP management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

NTES

NetEase

$236.92

0.17 (0.07%)

04:55
12/11/18
12/11
04:55
12/11/18
04:55
Conference/Events
NetEase management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

AKTS

Akoustis

$5.43

0.1 (1.88%)

04:55
12/11/18
12/11
04:55
12/11/18
04:55
Conference/Events
Akoustis management to meet with Roth Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

04:55
12/11/18
12/11
04:55
12/11/18
04:55
Conference/Events
Stephens construction analysts to hold an analsyt/industry conference call »

Construction Analysts,…

WPP

WPP

$51.13

-0.98 (-1.88%)

04:55
12/11/18
12/11
04:55
12/11/18
04:55
Conference/Events
WPP to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

ACM

Aecom

$28.14

-0.445 (-1.56%)

04:55
12/11/18
12/11
04:55
12/11/18
04:55
Conference/Events
Aecom to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

LNC

Lincoln National

$55.46

-0.92 (-1.63%)

04:55
12/11/18
12/11
04:55
12/11/18
04:55
Conference/Events
Lincoln National management to meet with Sandler O'Neill »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

MGPI

MGP Ingredients

$60.55

-1.02 (-1.66%)

04:55
12/11/18
12/11
04:55
12/11/18
04:55
Conference/Events
MGP Ingredients management to meet with SunTrust »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 17

    Dec

B

Barnes Group

$55.08

0.54 (0.99%)

04:55
12/11/18
12/11
04:55
12/11/18
04:55
Conference/Events
Barnes Group management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 12

    Dec

NOMD

Nomad Foods

$18.84

-0.24 (-1.26%)

04:55
12/11/18
12/11
04:55
12/11/18
04:55
Conference/Events
Nomad Foods management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

04:55
12/11/18
12/11
04:55
12/11/18
04:55
Conference/Events
Citigroup to hold a tour »

China Property/Financial…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.